Heart transplantation in adults with end-stage congenital heart disease

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 329-342

  Burchill, Luke J ^a   Ross, Heather J ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c NONE   (Canada)

Author keywords

adult congenital heart disease; Fontan; heart failure; risk stratification; sudden cardiac death; transplantation

Indexed keywords

BLEEDING; CONGENITAL HEART DISEASE; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFECTION; LONG TERM SURVIVAL; MORTALITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT CONTRAINDICATION;

EID: 84858696070     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.11     Document Type: Review

References (111)

1. Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation 123(7), 759-767 (2011
2. Karamlou T, Hirsch J, Welke K et al. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J. horac. Cardiovasc. Surg. 140(1), 161-168 (2010
3. Lindenfeld J, Albert NM, Boehmer JP et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J. Card. Fail. 16(6), e1-e194 (2010
4. Metra M, Ponikowski P, Dickstein K et al. AdVanced chronic heart failure: a position statement from the Study Group on AdVanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 9(6-7), 684-694 (2007 (Pubitemid 46705572)
5. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115(2), 163-172 (2007 (Pubitemid 46105714)
6. Warnes CA, Liberthson R, Danielson GK et al. Task force 1: the changing profile of congenital heart disease in adult life. J. Am. Coll. Cardiol. 37(5), 1170-1175 (2001
7. Hosseinpour AR, Cullen S, Tsang VT. Transplantation for adults with congenital heart disease. Eur. J. Cardiothorac. Surg. 30(3), 508-514 (2006 (Pubitemid 44209327)
8. Yap SC, Harris L, Chauhan VS, Oechslin EN, Silversides CK. Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am. J. Cardiol. 108(5), 723-728 (2011
9. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J. Am. Coll. Cardiol. 50(13), 1263-1271 (2007 (Pubitemid 47405126)
10. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ. Cardiovasc. Imaging 3(6), 727-734 (2010
11. Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118(23), e714-e833 (2008
12. Babu-Narayan SV, Goktekin O, Moon JC et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 111(16), 2091-2098 (2005 (Pubitemid 40577904)
13. Hornung TS, Kilner PJ, Davlouros PA, Grothues F, Li W, Gatzoulis MA. Excessive right ventricular hypertrophic response in adults with the Mustard procedure for transposition of the great arteries. Am. J. Cardiol. 90(7), 800-803 (2002 (Pubitemid 35279413)
14. Davlouros PA, Kilner PJ, Hornung TS et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J. Am. Coll. Cardiol. 40(11), 2044-2052 (2002 (Pubitemid 35425375)
15. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J. Am. Coll. Cardiol. 43(6), 1068-1074 (2004 (Pubitemid 38352990)
16. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J. Am. Coll. Cardiol. 40(9), 1675-1680 (2002 (Pubitemid 35253647)
17. Knauth AL, Gauvreau K, Powell AJ et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 94(2), 211-216 (2008 (Pubitemid 351211733)
18. Ouyang P, Saarel E, Bai Y et al. A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin. Chim. Acta 412(1-2), 170-175 (2011
19. Urbanek K, Cabral-da-Silva MC, Ide-Iwata N et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ. Res. 107(3), 429-441 (2010
20. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med. 325(5), 293-302 (1991
21. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med. 316(23), 1429-1435 (1987
22. Pfeffer MA, McMurray JJ, Velazquez EJ et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N. Engl. J. Med. 349(20), 1893-1906 (2003 (Pubitemid 37409706)
23. Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 112(16), 2411-2416 (2005 (Pubitemid 41504490)
24. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 96(5), 1507-1512 (1997 (Pubitemid 27375344)
25. Babu-Narayan SV, Uebing A, Davlouros PA et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation The APPROPRIATE study (ACE inhibitors for potential prevention of the deleterious effects of pulmonary regurgitation in adults with repaired tetralogy of Fallot). Int. J. Cardiol. 154(3), 299-305 (2010
26. Hechter SJ, Fredriksen PM, Liu P et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am. J. Cardiol. 87(5), 660-663, A11 (2001 (Pubitemid 32178472)
27. Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int. J. Cardiol. 129(2), 187-192 (2008
28. Tutarel O, Meyer GP, Bertram H, Wessel A, Schieffer B, Westhoff-Bleck M. Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle. Int. J. Cardiol. 154(1), 14-16 (2010
29. Bolger AP, Sharma R, Li W et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1), 92-99 (2002 (Pubitemid 34747447)
30. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am. J. Cardiol. 95(4), 474-478 (2005 (Pubitemid 40247541)
31. Hunt SA, Abraham WT, Chin MH et al.; American College of Cardiology Foundation, American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 53(15), e1-e90 (2009
32. Khairy P, Fernandes SM, Mayer JE Jr et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117(1), 85-92 (2008 (Pubitemid 350291185)
33. Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J. Heart Lung Transplant. 25(9), 1024-1042 (2006 (Pubitemid 44311532)
34. Uriel N, Jorde UP, Cotarlan V et al. Heart transplantation in human immunodeficiency virus-positive patients. J. Heart Lung Transplant. 28(7), 667-669 (2009
35. Patel ND, Weiss ES, Allen JG et al. Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. Ann. Thorac. Surg. 88(3), 814-821; discussion 821-822 (2009
36. Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J. Am. Coll. Cardiol. 58(5), 538-546 (2011
37. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J. Heart Transplant. 7(5), 331-336 (1988
38. Choong CK, Sweet SC, Guthrie TJ, Haddad FJ, Schuler P, De La Morena M, Huddleston CB. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13 year experience. J. horac. Cardiovasc. Surg. 129(3), 661-669 (2005 (Pubitemid 40311328)
39. Levy WC, Mozaffarian D, Linker DT et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113(11), 1424-1433 (2006 (Pubitemid 43739439)
40. Lund LH, Aaronson KD, Mancini DM. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in adVanced heart failure. Am. J. Cardiol. 95(6), 734-741 (2005 (Pubitemid 40332651)
41. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR et al. Cardiac transplantation after the Fontan or Glenn procedure. J. Am. Coll. Cardiol. 44(10), 2065-2072 (2004 (Pubitemid 39473293)
42. Krishnan US, Lamour JM, Hsu DT, Kichuk MR, Donnelly CM, Addonizio LJ. Management of aortopulmonary collaterals in children following cardiac transplantation for complex congenital heart disease. J. Heart Lung Transplant. 23(5), 564-569 (2004 (Pubitemid 38595741)
43. Januszewska K, Malec E, Juchem G et al. Heart-lung transplantation in patients with pulmonary atresia and ventricular septal defect. J. horac. Cardiovasc. Surg. 138(3), 738-743 (2009
44. Chandar JS, Wolff GS, Garson A Jr et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am. J. Cardiol. 65(9), 655-661 (1990 (Pubitemid 20091896)
45. Dietl CA, Cazzaniga ME, Dubner SJ, Perez-Balino NA, Torres AR, Favaloro RG. Life-threatening arrhythmias and RV dysfunction after surgical repair of tetralogy of Fallot. Comparison between transventricular and transatrial approaches. Circulation 90(5 Pt 2), II7-II12 (1994 (Pubitemid 24349236)
46. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356(9234), 975-981 (2000
47. Murphy JG, Gersh BJ, Mair DD et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N. Engl. J. Med. 329(9), 593-599 (1993 (Pubitemid 23244809)
48. Lense MD, Key AP, Dykens EM. Attentional disengagement in adults with Williams syndrome. Brain Cogn. 77(2), 201-207 (2011
49. Philip N, Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav. Genet. 41(3), 403-412 (2011
50. Bottega NA, Silversides CK, Oechslin EN, Dissanayake K, Harrison JL, Harris L. Stenosis of the superior limb of the systemic venous baffle following a Mustard procedure: an under-recognized problem. Int. J. Cardiol. 154(1), 32-37 (2012
51. Dimopoulos K, Diller GP, Giannakoulas G et al. Anemia in adults with congenital heart disease relates to adverse outcome. J. Am. Coll. Cardiol. 54(22), 2093-2100 (2009
52. Dimopoulos K, Diller GP, Koltsida E et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117(18), 2320-2328 (2008 (Pubitemid 351681557)
53. Dimopoulos K, Diller GP, Petraco R et al. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur. Heart J. 31(5), 595-601 (2010
54. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with adVanced heart failure. Eur. Heart J. 24(19), 1735-1743 (2003 (Pubitemid 37236862)
55. McDonagh TA, Cunningham AD, Morrison CE et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86(1), 21-26 (2001 (Pubitemid 32977774)
56. Tsutamoto T, Wada A, Maeda K et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur. Heart J. 20(24), 1799-1807 (1999
57. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109(23), 2872-2877 (2004 (Pubitemid 38780301)
58. Hopkins WE, Hall C. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease. Circulation 96(7), 2215-2220 (1997 (Pubitemid 27425825)
59. Giannakoulas G, Dimopoulos K, Bolger AP et al. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am. J. Cardiol. 105(6), 869-873 (2010
60. Diller GP, Dimopoulos K, Okonko D et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112(6), 828-835 (2005 (Pubitemid 41170068)
61. Fredriksen PM, Veldtman G, Hechter S et al. Aerobic capacity in adults with various congenital heart diseases. Am. J. Cardiol. 87(3), 310-314 (2001 (Pubitemid 32144872)
62. Trojnarska O, Gwizdala A, Katarzynski S et al. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Cardiol. J. 16(2), 133-141 (2009
63. Fernandes SM, Alexander ME, Graham DA et al. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit. Heart Dis. 6(4), 294-303 (2011
64. Dimopoulos K, Okonko DO, Diller GP et al. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 113(24), 2796-2802 (2006 (Pubitemid 44305291)
65. Diller GP, Dimopoulos K, Okonko D et al. Heart rate response during exercise predicts survival in adults with congenital heart disease. J. Am. Coll. Cardiol. 48(6), 1250-1256 (2006 (Pubitemid 44345139)
66. Diller GP, Giardini A, Dimopoulos K et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur. Heart J. 31(24), 3073-3083 (2010
67. Giardini A, Specchia S, Berton E et al. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am. Heart J. 154(3), 441-447 (2007 (Pubitemid 47268248)
68. Babu-Narayan SV, Kilner PJ, Li W et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 113(3), 405-413 (2006 (Pubitemid 43803202)
69. Giardini A, Lovato L, Donti A et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries. Am. J. Cardiol. 98(9), 1277-1282 (2006 (Pubitemid 44584118)
70. Rathod RH, Prakash A, Powell AJ, Geva T. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J. Am. Coll. Cardiol. 55(16), 1721-1728 (2010
71. Winter MM, Scherptong RW, Kumar S et al. Ventricular response to stress predicts outcome in adult patients with a systemic right ventricle. Am. Heart J. 160(5), 870-876 (2010
72. Khairy P, Dore A, Poirier N et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev. Cardiovasc. Ther. 7(7), 755-762 (2009
73. Gillette PC, Kugler JD, Garson A Jr, Gutgesell HP, Duff DF, McNamara DG. Mechanisms of cardiac arrhythmias after the Mustard operation for transposition of the great arteries. Am. J. Cardiol. 45(6), 1225-1230 (1980 (Pubitemid 10114058)
74. Janousek J, Paul T, Luhmer I, Wilken M, Hruda J, Kallfelz HC. Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death. Z. Kardiol. 83(12), 933-938 (1994
75. Kammeraad JA, Van Deurzen CH, Sreeram N et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J. Am. Coll. Cardiol. 44(5), 1095-1102 (2004 (Pubitemid 39165146)
76. Sarkar D, Bull C, Yates R et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation 100(19 Suppl.), II176-II181 (1999 (Pubitemid 29523531)
77. Schwerzmann M, Salehian O, Harris L et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur. Heart J. 30(15), 1873-1879 (2009
78. Yap SC, Harris L. Sudden cardiac death in adults with congenital heart disease. Expert. Rev. Cardiovasc. Ther. 7(12), 1605-1620 (2009
79. Everitt MD, Donaldson AE, Stehlik J et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J. Heart Lung Transplant. 30(4), 395-401 (2011
80. Hasan A, Au J, Hamilton JR, Hunter S, Hilton CJ, Dark JH. Orthotopic heart transplantation for congenital heart disease. Technical considerations. Eur. J. Cardiothorac. Surg. 7(2), 65-70 (1993
81. Menkis AH, McKenzie FN, Novick RJ et al. Special considerations for heart transplantation in congenital heart disease. The Paediatric Heart Transplant Group. J. Heart Transplant. 9(6), 602-607 (1990
82. Itescu S, Tung TC, Burke EM et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98(8), 786-793 (1998 (Pubitemid 28391844)
83. Kobashigawa JA, Sabad A, Drinkwater D et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? Circulation 94(9 Suppl), II294-II297 (1996 (Pubitemid 26363409)
84. Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann. Thorac. Surg. 84(5), 1556-1562; discussion 1562-1563 (2007
85. Suciu-Foca N, Reed E, Marboe C et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 51(3), 716-724 (1991
86. Pisani BA, Mullen GM, Malinowska K et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J. Heart Lung Transplant. 18(7), 701-706 (1999 (Pubitemid 29363032)
87. Kobashigawa J, Mehra M, West L et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J. Heart Lung Transplant. 28(3), 213-225 (2009
88. Bray RA, Nolen JD, Larsen C et al. Transplanting the highly sensitized patient: the emory algorithm. Am. J. ransplant. 6(10), 2307-2315 (2006 (Pubitemid 44359415)
89. Balfour IC, Fiore A, Graff RJ, Knutsen AP. Use of rituximab to decrease panel-reactive antibodies. J. Heart Lung Transplant. 24(5), 628-630 (2005 (Pubitemid 40693890)
90. Holt DB, Lublin DM, Phelan DL et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J. Heart Lung Transplant. 26(9), 876-882 (2007 (Pubitemid 47371287)
91. Itescu S, Burke E, Lietz K et al. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Circulation 105(10), 1214-1219 (2002 (Pubitemid 34225823)
92. Gonzalez-Stawinski GV, Cook DJ, Chang AS et al. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J. Heart Lung Transplant. 25(6), 613-618 (2006 (Pubitemid 43766580)
93. Pollock-BarZiv SM, den Hollander N, Ngan BY et al. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 116(11 Suppl.), I172-I178 (2007 (Pubitemid 47480787)
94. Stehlik J, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report - 2011. J. Heart Lung Transplant. 30(10), 1078-1094 (2011
95. Chen JM, Davies RR, Mital SR et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann. Thorac. Surg. 78(4), 1352-1361; discussion 1352-1361 (2004 (Pubitemid 39303863)
96. Lamour JM, Kanter KR, Naftel DC et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J. Am. Coll. Cardiol. 54(2), 160-165 (2009
97. Fan Y, Weng YG, Huebler M et al. Predictors of in-hospital mortality in children after long-term ventricular assist device insertion. J. Am. Coll. Cardiol. 58(11), 1183-1190 (2011
98. Agusala K, Bogaev R, Frazier OH, Franklin WJ. Ventricular assist device placement in an adult with D-transposition of the great arteries with prior Mustard operation. Congenit. Heart Dis. 5(6), 635-637 (2010
99. Arendt K, Doll S, Mohr FW. Failing Mustard circulation with secondary pulmonary hypertension: mechanical assist device to achieve reverse pulmonary vascular remodelling for subsequent heart transplantation. Heart 96(14), 1164 (2010
100. Joyce DL, Crow SS, John R et al. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J. Heart Lung Transplant. 29(11), 1302-1305 (2010
101. Frazier OH, Gregoric ID, Messner GN. Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure. Tex. Heart Inst. J. 32(3), 402-404 (2005 (Pubitemid 41306806)
102. Throckmorton AL, Carr JP, Tahir SA et al. Mechanical cavopulmonary assistance of a patient-specific Fontan physiology: numerical simulations, lumped parameter modeling, and suction experiments. Artif. Organs. 35(11), 1036-1047 (2011
103. Throckmorton AL, Kapadia JY, Chopski SG et al. Numerical, hydraulic, and hemolytic evaluation of an intravascular axial flow blood pump to mechanically support Fontan patients. Ann. Biomed. Eng. 39(1), 324-336 (2011
104. Bailey LL. Transplantation is the best treatment for hypoplastic left heart syndrome. Cardiol. Young 14(Suppl. 1), 109-111; discussion 112-104 (2004
105. Greutmann M, Pretre R, Furrer L et al. Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study. Transplant. Proc. 41(9), 3821-3826 (2009
106. Irving C, Parry G, O'SulliVan J et al. Cardiac transplantation in adults with congenital heart disease. Heart 96(15), 1217-1222 (2010
107. Pigula FA, Gandhi SK, Ristich J et al. Cardiopulmonary transplantation for congenital heart disease in the adult. J. Heart Lung Transplant. 20(3), 297-303 (2001 (Pubitemid 32197279)
108. Bernstein D, Naftel D, Chin C et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation 114(4), 273-280 (2006 (Pubitemid 44297093)
109. Spicer RL, Uzark KC, Moore JW, Mainwaring RD, Lamberti JJ. Aortopulmonary collateral vessels and prolonged pleural effusions after modified Fontan procedures. Am. Heart J. 131(6), 1164-1168 (1996 (Pubitemid 26176996)
110. Triedman JK, Bridges ND, Mayer JE Jr, Lock JE. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J. Am. Coll. Cardiol. 22(1), 207-215 (1993 (Pubitemid 23189954)
111. Haddad H, Isaac D, Legare JF et al. Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. Can. J. Cardiol. 25(4), 197-205 (2009)